MedPath

Efficacy and safety of Fluticasone furoate with montelukast vs Fluticasone furoate with Cetirizine in patients with allergic rhinitis

Phase 4
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Registration Number
CTRI/2023/10/059253
Lead Sponsor
SRM institute of science and technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Willing to sign informed consent form.

Patients suffering from Allergic Rhinitis.

Not being using Nasal steroids for past one month.

4 out of 12 Total Nasal Symptom Score(TNSS).

Exclusion Criteria

Pregnancy and lactating women.

Known history of psychiatric illness.

Planned surgery of nasal cavity.

Patient with unknown malignancies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath